EFFECTS OF PHENTOLAMINE, DIHYDROERGOCRISTINE AND ISOXSUPRINE ON THE BLOOD PRESSURE AND HEART RATE IN HORMOTENSIVE, HYPOTENSIVE AND HYPERTENSIVE RATS.MORPURGO C; FAINI D; FALCONE A et al.1975; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1975; VOL. 290; NO 4; PP. 335-346; BIBL. 16 REF.Article

Future strategies and adjuvant treatment of gastric cancerFALCONE, A.Annals of oncology. 2003, Vol 14, pp ii45-ii47, issn 0923-7534, SUP2Conference Paper

ACTH fragments reverse experimental haemorrhagic shock in ratsCOPPI, G; FALCONE, A.Drugs under experimental and clinical research. 1992, Vol 18, Num 5, pp 173-177, issn 0378-6501Article

The phytotropin releasing hormone analogue, RGH 2202, reverses experimental haemorrhagic shock in ratsCOPPI, G; FALCONE, A.European journal of pharmacology. 1990, Vol 182, Num 1, pp 185-188, issn 0014-2999, 4 p.Article

ANATOMIA CHIRURGICA DEL SISTEMA PORTALE NEL RATTO = ANATOMIE CHIRURGICALE DU SYSTEME PORTE CHEZ LE RATINNOCENTI P; COTELLESE R; FALCONE A et al.1978; BOLL. SOC. ITAL. BIOL. SPER.; ITA; DA. 1978 PUBL. 1979; VOL. 54; NO 23; PP. 2421-2425; BIBL. 2 REF.Article

An acute neurologic syndrome temporally associated with postexposure treatment of rabies. CommentaryMORTIERE, M. D; FALCONE, A. L; PLOTKIN, S.A et al.FALCONE, A. L; Pediatrics (Evanston). 1997, Vol 100, Num 4, pp 720-721, issn 0031-4005Article

FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancerLOUPAKIS, F; CREMOLINI, C; ANTONIOTTI, C et al.European journal of cancer (1990). 2014, Vol 50, Num 1, pp 57-63, issn 0959-8049, 7 p.Article

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancerBAJETTAL, E; FLORIANI, I; NITTI, D et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1373-1378, issn 0923-7534, 6 p.Article

FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO)FORNARO, L; LONARDI, S; ZANIBONI, A et al.Annals of oncology. 2013, Vol 24, Num 8, pp 2062-2067, issn 0923-7534, 6 p.Article

VERITAS OBSERVATIONS OF DAY-SCALE FLARING OF M 87 IN 2010 APRILALIU, E; ARLEN, T; CANNON, A et al.The Astrophysical journal. 2012, Vol 746, Num 2, issn 0004-637X, 141.1-141.7, 1Article

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patientsVINCENZI, B; GALLUZZO, S; RUZZO, A et al.Annals of oncology. 2011, Vol 22, Num 5, pp 1141-1146, issn 0923-7534, 6 p.Article

Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinibBOCCI, G; FALCONE, A; DEL TACCA, M et al.British journal of cancer. 2008, Vol 98, Num 10, pp 1619-1629, issn 0007-0920, 11 p.Article

GRB 050822 : detailed analysis of an XRF observed by SwiftGODET, O; PAGE, K. L; FALCONE, A et al.Astronomy and astrophysics (Berlin. Print). 2007, Vol 471, Num 2, pp 385-394, issn 0004-6361, 10 p.Article

SWIFT observations of TeV BL Lacertae objectsTRAMACERE, A; GIOMMI, P; ROMING, P et al.Astronomy and astrophysics (Berlin. Print). 2007, Vol 467, Num 2, pp 501-508, issn 0004-6361, 8 p.Article

Swift detection of all previously undetected blazars in a micro-wave flux-limited sample of WMAP foreground sourcesGIOMMI, P; CAPALBI, M; TRAMACERE, A et al.Astronomy and astrophysics (Berlin. Print). 2007, Vol 468, Num 2, pp 571-579, issn 0004-6361, 9 p.Article

The early X-ray emission from GRBsO'BRIEN, P. T; WILLINGALE, R; WELLS, A et al.The Astrophysical journal. 2006, Vol 647, Num 2, pp 1213-1237, issn 0004-637X, 25 p., 1Article

Swift and infra-red observations of the blazar 3C 454.3 during the giant X-ray flare of May 2005GIOMMI, P; BLUSTIN, A. J; TAGLIAFERRI, G et al.Astronomy and astrophysics (Berlin. Print). 2006, Vol 456, Num 3, pp 911-916, issn 0004-6361, 6 p.Article

T cells are necessary for Th₂ cytokine production and eosinophil accumulation in airways of antigen-challenged allergic miceGARLISI, C. G; FALCONE, A; KUNG, T. T et al.Clinical immunology and immunopathology (Print). 1995, Vol 75, Num 1, pp 75-83, issn 0090-1229Article

General pharmacology of pidotimod and testing for drug interactionsMANZARDO, S; FALCONE, A; PINZETTA, A et al.Arzneimittel-Forschung. 1994, Vol 44, Num 12A, pp 1441-1447, issn 0004-4172Article

5-fluorouracil enhances azidothymidine cytotoxicity : in vitro, in vivo, and biochemical studiesBRUNETTI, I; FALCONE, A; CALABRESI, P et al.Cancer research (Baltimore). 1990, Vol 50, Num 13, pp 4026-4031, issn 0008-5472, 6 p.Article

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumabLOUPAKIS, F; SCHIRRIPA, M; MARMORINO, F et al.British journal of cancer. 2013, Vol 108, Num 12, pp 2549-2556, issn 0007-0920, 8 p.Article

Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan―cetuximabSCARTOZZI, M; GIAMPIERI, R; LOUPAKIS, F et al.Annals of oncology. 2012, Vol 23, Num 7, pp 1706-1712, issn 0923-7534, 7 p.Article

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?SANTINI, D; VINCENZI, B; SCHIAVON, G et al.Annals of oncology. 2012, Vol 23, Num 9, pp 2313-2318, issn 0923-7534, 6 p.Article

Prognosis of mucinous histology for patients with radically resected stage II and III colon cancerCATALANO, V; LOUPAKIS, F; FORNARO, L et al.Annals of oncology. 2012, Vol 23, Num 1, pp 135-141, issn 0923-7534, 7 p.Article

VERITAS OBSERVATIONS OF SIX BRIGHT, HARD-SPECTRUM FERMI-LAT BLAZARSALIU, E; ARCHAMBAULT, S; CESARINI, A et al.The Astrophysical journal. 2012, Vol 759, Num 2, issn 0004-637X, 759102.1-759102.13, 1Article